On November 1, 2017 Cascadian Therapeutics, Inc. (NASDAQ:CASC), a clinical-stage biopharmaceutical company, reported that it will report its third quarter financial results after the close of the U.S. financial markets on Wednesday, November 8, 2017 (Press release, Cascadian Therapeutics, NOV 1, 2017, View Source [SID1234521383]). Following the financial results announcement, members of management will host a conference call and live audio webcast to discuss the results and provide a general corporate update. Access to the conference call can be obtained as follows:

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Live access on Wednesday, November 8, 2017

1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time

Telephone: +1 (877) 280-7291 (domestic) or +1 (707) 287-9361 (international)

Live webcast and replay will be available via the “Events & Presentations” page of the “News & Events” section of the Cascadian Therapeutics’ website at www.cascadianrx.com.